A detailed history of Schnieders Capital Management LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Schnieders Capital Management LLC holds 21,844 shares of NVO stock, worth $1.86 Million. This represents 0.5% of its overall portfolio holdings.

Number of Shares
21,844
Previous 22,184 1.53%
Holding current value
$1.86 Million
Previous $3.17 Million 17.88%
% of portfolio
0.5%
Previous 0.64%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$119.07 - $145.42 $40,483 - $49,442
-340 Reduced 1.53%
21,844 $2.6 Million
Q2 2024

Aug 13, 2024

SELL
$122.71 - $146.91 $21,965 - $26,296
-179 Reduced 0.8%
22,184 $3.17 Million
Q1 2024

Apr 25, 2024

BUY
$102.11 - $135.92 $88,325 - $117,570
865 Added 4.02%
22,363 $2.87 Million
Q4 2023

Feb 01, 2024

BUY
$87.78 - $105.45 $624,993 - $750,804
7,120 Added 49.52%
21,498 $2.22 Million
Q3 2023

Nov 07, 2023

BUY
$90.94 - $199.54 $755,620 - $1.66 Million
8,309 Added 136.91%
14,378 $1.31 Million
Q2 2023

Aug 01, 2023

BUY
$155.98 - $172.65 $15,597 - $17,265
100 Added 1.68%
6,069 $982,000
Q2 2021

Aug 10, 2021

BUY
$67.66 - $84.76 $93,032 - $116,545
1,375 Added 29.93%
5,969 $500,000
Q3 2020

Nov 05, 2020

SELL
$63.69 - $70.22 $28,660 - $31,599
-450 Reduced 8.92%
4,594 $319,000
Q2 2020

Aug 07, 2020

BUY
$58.54 - $67.94 $8,781 - $10,191
150 Added 3.06%
5,044 $330,000
Q1 2020

May 08, 2020

BUY
$49.46 - $64.78 $14,838 - $19,434
300 Added 6.53%
4,894 $295,000
Q4 2019

Feb 07, 2020

SELL
$49.86 - $58.26 $20,093 - $23,478
-403 Reduced 8.06%
4,594 $266,000
Q2 2019

Aug 07, 2019

SELL
$46.79 - $52.47 $28,074 - $31,482
-600 Reduced 10.72%
4,997 $255,000
Q1 2019

May 03, 2019

BUY
$46.36 - $52.63 $27,816 - $31,578
600 Added 12.01%
5,597 $292,000
Q2 2018

Aug 13, 2018

SELL
$44.29 - $50.42 $8,858 - $10,084
-200 Reduced 3.85%
4,997 $230,000
Q3 2017

Nov 13, 2017

BUY
$41.15 - $49.22 $213,856 - $255,796
5,197
5,197 $250,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $192B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Schnieders Capital Management LLC Portfolio

Follow Schnieders Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schnieders Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schnieders Capital Management LLC with notifications on news.